These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15895886)
1. Elevated whole blood chemiluminescence in patients with systemic sclerosis. Luczynska M; Szkudlarek U; Dziankowska-Bartkowiak B; Waszczykowska E; Kasielski M; Jozefowicz-Okonkwo G; Nowak D Clin Exp Rheumatol; 2005; 23(2):173-9. PubMed ID: 15895886 [TBL] [Abstract][Full Text] [Related]
2. Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study. Štorkánová H; Oreská S; Špiritović M; Heřmánková B; Bubová K; Komarc M; Pavelka K; Vencovský J; Distler JHW; Šenolt L; Bečvář R; Tomčík M Sci Rep; 2021 Jan; 11(1):1. PubMed ID: 33414495 [TBL] [Abstract][Full Text] [Related]
3. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment. Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465 [TBL] [Abstract][Full Text] [Related]
4. Comparison of circulating phagocyte oxidative activity measured by chemiluminescence in whole blood and isolated polymorphonuclear leukocytes. Kopprasch S; Graessler J; Kohl M; Bergmann S; Schröder HE Clin Chim Acta; 1996 Sep; 253(1-2):145-57. PubMed ID: 8879845 [TBL] [Abstract][Full Text] [Related]
5. Increased exhaled H2O2 and impaired lung function in patients undergoing bioincompatible hemodialysis. Rysz J; Stolarek RA; Pedzik A; Fijalkowska J; Luczynska M; Sarniak A; Kasielski M; Makowka A; Nowicki M; Nowak D Int J Artif Organs; 2007 Oct; 30(10):879-88. PubMed ID: 17992648 [TBL] [Abstract][Full Text] [Related]
6. Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Szkudlarek U; Maria L; Kasielski M; Kaucka S; Nowak D Respir Med; 2003 Jun; 97(6):718-25. PubMed ID: 12814160 [TBL] [Abstract][Full Text] [Related]
7. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis. Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784 [TBL] [Abstract][Full Text] [Related]
8. The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ho KJ; Chen PQ; Chang CY; Lu FJ Ann Rheum Dis; 2000 May; 59(5):338-41. PubMed ID: 10784514 [TBL] [Abstract][Full Text] [Related]
9. Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide. Pernot J; Puzenat E; Magy-Bertrand N; Manzoni P; Gondouin A; Bourdin H; Simon-Rigaud ML; Regnard J; Degano B Respiration; 2012; 84(6):461-8. PubMed ID: 22301769 [TBL] [Abstract][Full Text] [Related]
10. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP; Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967 [TBL] [Abstract][Full Text] [Related]
11. Elevated resting and agonist-induced whole blood chemiluminescence in patients with active infective endocarditis. Ostrowski S; Kasielski M; Kordiak J; Nowak D Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):12-6. PubMed ID: 18829610 [TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309 [TBL] [Abstract][Full Text] [Related]
13. Phagocyte oxidative metabolism in cyclosporine- or placebo-treated patients with insulin-dependent (type I) diabetes mellitus of recent onset. Descamps-Latscha B; Nguyen AT; Feutren G J Autoimmun; 1990 Apr; 3(2):201-13. PubMed ID: 2187453 [TBL] [Abstract][Full Text] [Related]
14. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study. Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis. Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649 [TBL] [Abstract][Full Text] [Related]
16. No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea. Grabska-Kobylecka I; Kobylecki A; Bialasiewicz P; Krol M; Ehteshamirad G; Kasielski M; Nowak D J Negat Results Biomed; 2008 Nov; 7():10. PubMed ID: 19032755 [TBL] [Abstract][Full Text] [Related]
17. Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells. Kopprasch S; Pietzsch J; Graessler J Luminescence; 2003; 18(5):268-73. PubMed ID: 14587078 [TBL] [Abstract][Full Text] [Related]
18. Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis. Takahashi T; Asano Y; Akamata K; Aozasa N; Taniguchi T; Noda S; Masui Y; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S Mod Rheumatol; 2013 Sep; 23(5):884-90. PubMed ID: 22972016 [TBL] [Abstract][Full Text] [Related]
19. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement. Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918 [TBL] [Abstract][Full Text] [Related]
20. Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers. Anderson R; Theron AJ; Ras GJ Lung; 1988; 166(3):149-59. PubMed ID: 3132577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]